$1 is cheap as chips when you consider the anticipated trials. COH paper suggests that Bisantrene is the drug of choice, rivalling thousands of other drugs. My honest opinion has Race with a market cap of $500m in the very near term, by December in my reckoning. Lots of data already proves that Bisantrene works. The team at Race give me no reason to be fearful of the future.
$1 is cheap as chips when you consider the anticipated trials....
-
- There are more pages in this discussion • 202 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.83 |
Change
-0.030(1.61%) |
Mkt cap ! $313.4M | |||
| Open | High | Low | Value | Volume |
| $1.86 | $1.91 | $1.79 | $169.3K | 92.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 92 | $1.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 3472 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |